Literature DB >> 26549493

Clostridium difficile infection and intestinal microbiota interactions.

C Rodriguez1, B Taminiau2, J Van Broeck3, M Delmée3, G Daube2.   

Abstract

Clostridium difficile remains the leading cause of healthcare-associated diarrhoea and outbreaks continue to occur worldwide. Aside from nosocomial C. difficile infection, the bacterium is also increasingly important as a community pathogen. Furthermore, asymptomatic carriage of C. difficile in neonates, adults and animals is also well recognised. The investigation of the gut's microbial communities, in both healthy subjects and patients suffering C. difficile infection (CDI), provides findings and information relevant for developing new successful approaches for its treatment, such as faecal microbiota transplantation, or for the prophylaxis of the infection by modification of the gut microbiota using functional foods and beverages. The analysis of all available data shows new insights into the role of intestinal microbiota in health and disease.
Copyright © 2015 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Clostridium difficile; Colonisation; Infection; Intestinal microbiota

Mesh:

Year:  2015        PMID: 26549493     DOI: 10.1016/j.micpath.2015.10.018

Source DB:  PubMed          Journal:  Microb Pathog        ISSN: 0882-4010            Impact factor:   3.738


  10 in total

Review 1.  Nutrition and the gut microbiome in the elderly.

Authors:  Nuria Salazar; Lorena Valdés-Varela; Sonia González; Miguel Gueimonde; Clara G de Los Reyes-Gavilán
Journal:  Gut Microbes       Date:  2016-11-03

Review 2.  Neutrophil-mediated inflammation in the pathogenesis of Clostridium difficile infections.

Authors:  Shinsmon Jose; Rajat Madan
Journal:  Anaerobe       Date:  2016-04-05       Impact factor: 3.331

3.  Massilioclostridium coli gen. nov., sp. nov., a new member of the Clostridiaceae family isolated from the left colon of a 27-year-old woman.

Authors:  C I Lo; M Mailhe; D Ricaboni; V Vitton; A Benezech; C Michelle; N Armstrong; F Bittar; P-E Fournier; D Raoult; J-C Lagier
Journal:  New Microbes New Infect       Date:  2017-01-16

4.  Acetate coordinates neutrophil and ILC3 responses against C. difficile through FFAR2.

Authors:  José Luís Fachi; Cristiane Sécca; Patrícia Brito Rodrigues; Felipe Cézar Pinheiro de Mato; Blanda Di Luccia; Jaqueline de Souza Felipe; Laís Passariello Pral; Marcella Rungue; Victor de Melo Rocha; Fabio Takeo Sato; Ulliana Sampaio; Maria Teresa Pedrosa Silva Clerici; Hosana Gomes Rodrigues; Niels Olsen Saraiva Câmara; Sílvio Roberto Consonni; Angélica Thomaz Vieira; Sergio Costa Oliveira; Charles Reay Mackay; Brian T Layden; Karina Ramalho Bortoluci; Marco Colonna; Marco Aurélio Ramirez Vinolo
Journal:  J Exp Med       Date:  2020-03-02       Impact factor: 14.307

5.  High-throughput screening identifies a novel natural product-inspired scaffold capable of inhibiting Clostridioides difficile in vitro.

Authors:  Rusha Pal; Mingji Dai; Mohamed N Seleem
Journal:  Sci Rep       Date:  2021-05-25       Impact factor: 4.379

6.  Clostridioides difficile Infection in Patients with Inflammatory Bowel Disease May be Favoured by the Effects of Proinflammatory Cytokines on the Enteroglial Network.

Authors:  Gabrio Bassotti; Alessandro Fruganti; Giovanni Maconi; Pierfrancesco Marconi; Katia Fettucciari
Journal:  J Inflamm Res       Date:  2021-12-30

7.  Antibiotic Resistance Profile of RT 027/176 Versus Other Clostridioides difficile Isolates in Silesia, Southern Poland.

Authors:  Małgorzata Aptekorz; Krzysztof Sacha; Zygmunt Gofron; Monika Kabała; Celine Harmanus; Ed Kuijper; Gayane Martirosian
Journal:  Pathogens       Date:  2022-08-22

8.  In Silico Prediction and Prioritization of Novel Selective Antimicrobial Drug Targets in Escherichia coli.

Authors:  Frida Svanberg Frisinger; Bimal Jana; Stefano Donadio; Luca Guardabassi
Journal:  Antibiotics (Basel)       Date:  2021-05-25

9.  Longitudinal survey of Clostridium difficile presence and gut microbiota composition in a Belgian nursing home.

Authors:  Cristina Rodriguez; Bernard Taminiau; Nicolas Korsak; Véronique Avesani; Johan Van Broeck; Philippe Brach; Michel Delmée; Georges Daube
Journal:  BMC Microbiol       Date:  2016-10-01       Impact factor: 3.605

Review 10.  Novel Antimicrobials for the Treatment of Clostridium difficile Infection.

Authors:  Nicola Petrosillo; Guido Granata; Maria Adriana Cataldo
Journal:  Front Med (Lausanne)       Date:  2018-04-16
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.